Clinical Trial Update: Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP [NA]

View source ↗

Summary

A clinical trial comparing propofol and dexmedetomidine for sedation in cancer patients undergoing ERCP has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• PROPOFOL (Propofol)

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Sedation in ERCP | NA | Status: COMPLETED